No Data
12 Health Care Stocks Moving In Thursday's Pre-Market Session
BioLineRx Inks Licensing Deal, Share Purchase Agreement
BioLineRx And Ayrmid Entered Into A License Agreement For Motixafortide (Commercially Sold In The US As Aphexda), BioLineRx Will Receive A $10M Upfront Payment And Is Also Eligible To Receive Up To An Additional $87M Of Potential Commercial...
Express News | BioLine RX Ltd - Transactions to Reduce Biolinerx's Operational Expenses and Debt
Express News | BioLine RX Ltd - Biolinerx to Receive $10 Mln Upfront, up to $87 Mln in Milestones
Earnings Preview: BioLine Rx to Report Financial Results Pre-market on November 25
No Data
No Data
